Skip to main content

On Dec. 9, 2011, five insiders of Montana-focused Rx Exploration bought a total of 675,000 shares in the public market at 40 cents. CEO Darren Blasutti was one of the buyers, picking up 250,000 shares, which brought his total ownership to 1,250,000 shares. More recently, on Jan. 6, director Lorie Waisberg bought 13,000 shares at 37 cents. The company went through a boardroom shuffle last year that saw a new management team installed. This month, shareholders voted to change the name to RX Gold & Silver.



Ted Dixon is CEO of INK Research which provides insider news and knowledge to investors. For more background on insider reporting in Canada, visit the FAQ section at www.inkresearch.com. Securities referenced in this profile may have already appeared in recent reports distributed to INK subscribers. INK staff may also hold a position in profiled securities.





Report an error Editorial code of conduct
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.